Extended Use of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 1 Diabetes: 12-Month Extension of a Randomized Controlled Trial.
This 12-month extension of a randomized controlled trial evaluated the Omnipod 5 Automated Insulin Delivery System in 75 adults with Type 1 diabetes.
Why it matters
The study provides evidence that the Omnipod 5 AID system can sustain glycemic control and improve quality of life in adults with Type 1 diabetes, which is crucial for long-term diabetes management.